home / stock / nsrgy / nsrgy news


NSRGY News and Press, Nestle SA ADR Reg Shs Ser B From 12/13/22

Stock Information

Company Name: Nestle SA ADR Reg Shs Ser B
Stock Symbol: NSRGY
Market: OTC

Menu

NSRGY NSRGY Quote NSRGY Short NSRGY News NSRGY Articles NSRGY Message Board
Get NSRGY Alerts

News, Short Squeeze, Breakout and More Instantly...

NSRGY - Nestle is one of the first major companies to make post-war factory investment in Ukraine

Nestle ( OTCPK:NSRGY ) plans to invest in a new production facility in the western part of Ukraine. The $42.9M investment will be for a new production facility in  Smolyhiv in the Volyn region. The company will use the site to boost production of cold sauces, seasonings...

NSRGY - IQDG: Balanced, But Unattractive Dividend Growth ETF

Summary IQDG is a large-cap, ex-US dividend growth ETF. 79% of asset value is in European companies. It is well-balanced across sectors, but quite concentrated in the top holdings. Past performance is underwhelming relative to its peers. IQDG's strategy and portfolio...

NSRGY - Nestlé: I Take A Bullish View

Summary Nestlé S.A. has seen strong sales growth this year. In spite of higher prices, demand has continued to remain strong. I take a long-term bullish view on Nestlé S.A. Investment Thesis: I take a long-term bullish view on Nestlé S.A. owing to strong sal...

NSRGY - Tracking Gardner Russo & Quinn Portfolio - Q3 2022 Update

Summary Gardner Russo & Quinn’s 13F portfolio value decreased from $8.94B to $8.27B. Russo increased Netflix and Ashtead Group plc while reducing Comcast and dropping Alibaba Group Holdings during the quarter. The top three 13F stakes are Berkshire Hathaway, Nestle,...

NSRGY - Seres Gets Closer To Good Times

Summary After accepting the BLA for SER-109, the FDA has not announced the need for an expert advisory committee. The FDA provides a firm date (April 26, 2023) for its decision concerning approval of SER-109. Big focus on SER-155 and other bacterial infections to follow SER-10...

NSRGY - Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2022 Update

Summary Fisher’s 13F portfolio value decreased from ~$141B to ~$133B in Q3 2022. They added Charles Schwab and increased Nvidia, Morgan Stanley, and Goldman Sachs while decreasing Salesforce, Visa, Alibaba Group Holdings, Novartis, Verizon, and Tencent Holdings. The top...

NSRGY - My 2 Current Favorite Markets - Paris And Zurich

Summary Valuation is core to everything that I do - second to nothing. The current valuation trends on a high level, for the overall stock markets, show very clear indications. Those indications are that several markets are currently significantly undervalued - on a very broad bas...

NSRGY - Nestlé: Pricing Is Driving Growth

Summary Nestlé's revenues are not suffering from the current macroeconomic problems. I expect Nestlé stock to outperform the S&P500 if inflation remains high. Nestlé is focusing heavily on offering new healthy products. The difficulties of the macr...

NSRGY - The Real Reason Starbucks Is Selling the Seattle's Best Brand

Starbucks (NASDAQ: SBUX) is selling its Seattle's Best coffee brand as it continues to narrow its vision about what the coffee experience means. Where once that meant bakeries, health foods, and coffee brands -- all at different price points -- today the beverage behemoth has winnow...

NSRGY - ClearBridge International Growth EAFE Strategy Q3 2022 Portfolio Manager Commentary

Summary The Strategy outperformed for the second quarter in a row, thanks in large part to positioning adjustments made over the last year in preparation for these extreme macro headwinds. We enhanced a focus on sturdy, secular growth businesses with three new additions to the portfol...

Previous 10 Next 10